Developments beyond blood group serology in the genomics era

Br J Haematol. 2019 Mar;184(6):897-911. doi: 10.1111/bjh.15747. Epub 2019 Feb 1.

Abstract

Blood group serology and single nucleotide polymorphism-based genotyping platforms are accurate but do not provide a comprehensive cover for all 36 blood group systems and do not cover the antigen diversity observed among population groups. This review examines the extent to which genomics is shaping blood group serology. Resources for genomics include the Human Reference Genome Sequence assembly; curated blood group tables listing variants; public databases providing information on genetic variants from world-wide studies; and massively parallel sequencing technologies. Blood group genomic studies span the spectrum, from bioinformatic data mining of huge data sets containing whole genome and whole exome information to laboratory investigations utilising targeted sequencing approaches. Blood group predictions based on genome sequencing and genomic studies are proving accurate, and have shown utility in both research and reference settings. Overall, studies confirm the potential for blood group genomics to reshape donor and patient transfusion management strategies to provide more compatible blood transfusions.

Keywords: blood groups; genomics; massively parallel sequencing; next generation sequencing; serology.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Blood Group Antigens / genetics*
  • Genomics / methods*
  • Humans
  • Sequence Analysis, DNA / methods*

Substances

  • Blood Group Antigens